AKT1 Transcriptomic Landscape in Breast Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Overexpression of the serine/threonine protein kinase B (AKT) pathway is common in breast cancer progression.
• The specific genome-wide transcriptomic effects of AKT1 in breast cancer are not well understood.

Purpose of the Study:

• To investigate the genome-wide transcriptomic alterations caused by modulating AKT1 activity in breast cancer cells.
• To identify AKT1-dependent gene expression changes and uncover novel AKT1 functions.

Main Methods:

• Utilized gene-specific siRNAs for AKT1 knockdown and a pan-AKT inhibitor VIII to reduce AKT activity.
• Performed genome-wide RNA-sequencing analysis on breast cancer cells.
• Validated RNA-sequencing findings using qRT-PCR and ex vivo studies on patient-derived cells.

Main Results:

• Modulating AKT1 levels significantly altered the expression of numerous genes in breast cancer cells.
• Discovered an unexpected inhibitory role of AKT1 on a subset of genes, independent of stimulation.
• Depletion of AKT1 led to the upregulation of genes that are downregulated in tumors with high AKT1 expression.

Conclusions:

• AKT1 plays a dual role in gene expression regulation in breast cancer, both promoting and inhibiting gene expression.
• These findings provide a valuable resource for understanding AKT1-mediated gene modulation and expanding the known targets and functions of AKT1 in breast cancer.